Holding(s) in Company
Redmile Group, LLC, through its managed entities, has reduced its holding in Scancell Holdings plc to 24.52% of the voting rights, down from a previous notification of 28.95%. This change is due to a new share issuance by the company, resulting in a total of 297,188,365 voting rights held by Redmile Group's entities, including RedCo I, L.P. and Redmile Biopharma Investments II, L.P. The notification was made on 30 July 2026, with the threshold crossing occurring on 28 July 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your SCLP notes
| 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Scancell Holdings plc |
- Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
- Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
| Other (please specify): New Share issuance by issuer | X |
| 3. Details of person subject to the notification obligation | |
| Name | Redmile Group, LLC |
| City and country of registered office (if applicable) | Larkspur, USA |
| 4. Full name of shareholder(s) (if different from 3.) | |
| Name | RedCo I, L.P. Redmile Biopharma Investments II, L.P. Redmile Capital Offshore II Master Fund, Ltd. Redmile Capital Offshore II Master Fund, Ltd. (Strategic Sleeve) Redmile Strategic Long Only Trading Sub, Ltd. Redmile Strategic Trading Sub, Ltd. |
| City and country of registered office (if applicable) | Larkspur, USA |
| 5. Date on which the threshold was crossed or reached: | 28/07/2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 30/07/2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 24.52 | N/A | 24.52 | 297,188,365 |
| Position of previous notification (if applicable) | 28.95 | N/A | 28.95 | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| Ordinary Shares GB00B63D3314 | N/A | 297,188,365 | N/A | 24.52 |
| SUBTOTAL 8. A | 297,188,365 | 24.52 | ||
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| RedCo I, L.P. | 7.27% | N/A | 7.27% |
| Redmile Biopharma Investments II, L.P. | 9.50% | N/A | 9.50% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information
Redmile Group, LLC is the investment manager for: RedCo I, L.P; Redmile Biopharma Investments II, L.P.; Redmile Capital Offshore II Master Fund, Ltd.; Redmile Capital Offshore II Master Fund, Ltd. (Strategic Sleeve); Redmile Strategic Long Only Trading Sub, Ltd.; and Redmile Strategic Trading Sub, Ltd.
| Place of completion | Larkspur, USA |
| Date of completion | 30/07/2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.